COMPANY PROFILE

Sedatice

Explore full profile

Life sciences company specialized in the R and D of anesthetics and analgesics

Adelaide, AustraliaFounded 2016Biotech & Life Sciences

Valuation $100–250M Last recorded · 2018

Total funding $10–50M Disclosed equity funding

At a glance

Status: Closed
Founded: 2016
Headquarters: Adelaide, Australia
Open positions: None listed
Dealroom signal: 0.0/100
Industry: Health
Sub-industry: BioTechnology
Sector: Biotech & Life Sciences, Biotechnology, Biotech and Pharma, Hard Tech, DT and LS, science-based
Business model: Manufacturing
Client focus: b2b
Links: Website

Founder mafia, market maps, research and news connected to this company by Dealroom

2 recorded events

Company financing events and reported valuations.

Deal type	Date	Amount	Valuation	Investors	Source
SERIES A✓Equity / VC	Sep 2018	$29M	$118M	Undisclosed	—
SEED✓Equity / VC	Jun 2016	$9.7M	$39M	Undisclosed	—

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Company	Headquarters	Status	Employees	Total funding	Valuation
HLHeranova LifesciencesA Boston-based biotech company solely focused on developing integrated care solutions for women's health issues	Burlington, United States	Operational	21	$24M	$54M
VBVega BioImagingOffering plasmonic nanoparticles , typically from gold and silver alloys, applied as optical markers for biochemical or biomedical diagnostics	Montreal, Canada	Operational
ATAtG TherapeuticsAt AtG, we develop novel classes of medicines and biomarkers to prevent cancer therapeutic resistance	L'Hospitalet de Llobregat, Spain	Operational
BPBio PaletteBio Palette aims to become a world-leading company in the field of microbiome therapeutics by using bacteria optimized by genome editing to modify and control microbiomes	Kobe, Japan	Operational
IAImmunito AIAn in-silico Antibody Discovery company which uses Artificial Intelligence to give the fastest and most accurate solutions	Bengaluru, India	Operational
SISideROSFocused on accelerated development of innovative small molecules targeting tumour cells metabolism in high-risk cancers	Paris, France	Closed
KTKintsugi TherapeuticsDevelopment of ER stress inhibitors for the treatment of metabolic diseases	Barcelona, Spain	Operational
ASASYLIACompanion Diagnostics For Immunotherapy \| Asylia Diagnostics	Beerse, Belgium	Operational